Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m641 · Cited by 727

Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis

Section of Precision Medicine Group of Chinese Society of Cardiology, Wang, D. W., Editorial Board of Chinese Journal of Cardiology, Working Group of Adult Fulminant Myocarditis, Li, S., Jiang, J., Yan, J., Zhao, C., Wang, Y., Ye-xin, M., et al. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9385-3 · Cited by 128

Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure

Badary, O. A., Hamza, M. S., & Tikamdas, R. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s308863 · Cited by 76

Pathophysiological mechanisms of thrombosis in acute and long COVID-19

Jing, H., Wu, X., Xiang, M., Liu, L., Novakovic, V. A., & Shi, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.992384 · Cited by 81

The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection

Qudus, M. S., Tian, M., Sirajuddin, S., Liu, S., Afaq, U., Wali, M., Liu, J., Pan, P., Luo, Z., Zhang, Q., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28751 · Cited by 84

Widely available lysosome targeting agents should be considered as potential therapy for COVID-19

Homolak, J., & Kodvanj, I. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106044 · Cited by 74

Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan

Tu, W., Cao, J., Yu, L., Hu, X., & Liu, Q. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06023-4 · Cited by 83

Ictus como complicación y como factor pronóstico de COVID-19

Trejo-Gabriel-Galan, J. M. (2020) · Neurología · doi:10.1016/j.nrl.2020.04.015 · Cited by 80

Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review

Roshanravan, N., Seif, F., Ostadrahimi, A., Pouraghaei, M., & Ghaffari, S. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.06.012 · Cited by 77

COVID-19 and the renin-angiotensin system (RAS): A spark that sets the forest alight?

Wiese, O. J., Allwood, B., & Zemlin, A. E. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110231 · Cited by 75

Clinical characteristics and manifestations in older patients with COVID-19

Wei, C., Liu, Y., Liu, Y., Zhang, K., Su, D., Zhong, M., & Xiao, M. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01811-5 · Cited by 75

The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines

Luban, J., Sattler, R. A., Mühlberger, E., Graci, J. D., Cao, L., Weetall, M. L., Trotta, C. R., Colacino, J. M., Bavari, S., Strambio‐De‐Castillia, C., et al. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198246 · Cited by 74

IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Staines, H. M., Kirwan, D. E., Clark, D. J., Adams, E. R., Augustin, Y. S., Byrne, R. L., Cocozza, M., Cubas-Atienzar, A. I., Cuevas, L. E., Cusinato, M., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2701.203074 · Cited by 77

Severity Scores in COVID-19 Pneumonia: a Multicenter, Retrospective, Cohort Study

Artero, A., Madrazo, M., Fernández‐Garcés, M., Míguez, A. M., García, A. G., Vieitez, A. C., Guijarro, E. G., Aizpuru, E. M. F., Gómez, M. G., Manrique, M. A., et al. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06626-7 · Cited by 75

COVID-19 and Hypertension: The What, the Why, and the How

Muhamad, S.-A., Ugusman, A., Kumar, J., Skiba, D. S., Hamid, A. A., & Aminuddin, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.665064 · Cited by 76

Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID

Clough, E., Inigo, J., Chandra, D., Chaves, L., Reynolds, J. L., Aalinkeel, R., Schwartz, S. A., Khmaladze, A., & Mahajan, S. D. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10015-6 · Cited by 75

Viral Myocarditis—From Pathophysiology to Treatment

Schultheiss, H.-P., Baumeier, C., Aleshcheva, G., Bock, C.-T., & Escher, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225240 · Cited by 75

Immunomodulatory Drugs in the Management of SARS-CoV-2

Burrage, D., Koushesh, S., & Sofat, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01844 · Cited by 74

COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management

Fraiman, P. H. A., Godeiro-Junior, C. D. O., Moro, E., Cavallieri, F., & Zedde, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.574694 · Cited by 78

Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections

Bonam, S. R., Kotla, N. G., Bohara, R. A., Rochev, Y. A., Webster, T. J., & Bayry, J. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101051 · Cited by 76

Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial

Arnardottir, H. H., Pawelzik, S., Öhlund‐Wistbacka, U., Artiach, G., Hofmann, R., Reinholdsson, I., Braunschweig, F., Tornvall, P., Religa, D., & Bäck, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.624657 · Cited by 75

The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19

El-Arif, G., Farhat, A., Khazaal, S., Annweiler, C., Kovacic, H., Wu, Y., Cao, Z., Fajloun, Z., Khattar, Z. A., & Sabatier, J. (2021) · Molecules · doi:10.3390/molecules26226945 · Cited by 76

Spatial Variation in Socio-ecological Vulnerability to COVID-19 in the Contiguous United StatesPreprint

Snyder, B. F., & Parks, V. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3587713 · Cited by 74

A rationale for targeting the P2X7 receptor in Coronavirus disease 19

Di Virgilio, F., Tang, Y., Sarti, A. C., & Rossato, M. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15138 · Cited by 71

In the eye of the storm: the right ventricle in COVID‐19

Park, J. F., Banerjee, S., & Umar, S. (2020) · Pulmonary Circulation · doi:10.1177/2045894020936660 · Cited by 73

The value of ECG changes in risk stratification of COVID‐19 patients

Bergamaschi, L., D’Angelo, E. C., Paolisso, P., Toniolo, S., Fabrizio, M., Angeli, F., Donati, F., Magnani, I., Rinaldi, A., Bartoli, L., et al. (2021) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12815 · Cited by 72

Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19

Baiou, A., Elbuzidi, A. A. S., Bakdach, D., Zaqout, A., Alarbi, K. M. S., Bintaher, A., Ali, M. M. B., Elarabi, A., Ali, G. A. M., Daghfal, J., et al. (2021) · Journal of Hospital Infection · doi:10.1016/j.jhin.2021.01.027 · Cited by 72

The most important biomarker associated with coagulation and inflammation among COVID-19 patients

Hong, L.-Z., Shou, Z., Zheng, D.-M., & Jin, X. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04122-4 · Cited by 73

Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19

Pepperrell, T., Pilkington, V., Owen, A., Wang, J., & Hill, A. M. (2020) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30017-0 · Cited by 72

JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome

Tuttle, K. D., Waugh, K. A., Araya, P., Minter, R., Orlicky, D. J., Ludwig, M., Andrysik, Z., Burchill, M. A., Tamburini, B. A. J., Sempeck, C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108407 · Cited by 72

Isolation and Contact Tracing Can Tip the Scale To Containment of COVID-19 In Populations with Social Distancing

Kretzschmar, M., Rozhnova, G., & van Boven, M. (2020) · Frontiers in Physics · doi:10.3389/fphy.2020.622485 · Cited by 82

Potential relationships between COVID-19 and the thyroid gland: an update

Naguib, R. (2022) · Journal of International Medical Research · doi:10.1177/03000605221082898 · Cited by 76

Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty

Cheng, P. P., Zhu, H., Witteles, R. M., Wu, J. C., Quertermous, T., Wu, S. M., & Rhee, J. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01293-2 · Cited by 71

Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas

Bernhardt, D., Wick, W., Weiss, S. E., Sahgal, A., Lo, S. S.-M., Suh, J. H., Chang, E. L., Foote, M. C., Perry, J., Meyer, B., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa113 · Cited by 71

Overcoming Barriers

Gustafson, D., Raju, S., Wu, R., Ching, C., Veitch, S., Rathnakumar, K., Boudreau, É., Howe, K. L., & Fish, J. E. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314558 · Cited by 75

Impact of Comorbidities in Mexican SARS-CoV-2-Positive Patients: A Retrospective Analysis in a National Cohort

Kammar‐García, A., Vidal-Mayo, J. D. J., Vera-Zertuche, J. M., Lazcano-Hernández, M., Verá-López, O., Segura-Badilla, O., Aguilar‐Alonso, P., & Navarro-Cruz, A. R. (2020) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.20000207 · Cited by 69

HIV infection and COVID-19: risk factors for severe disease

Etienne, N., Karmochkine, M., Slama, L., Pavie, J., Batisse, D., Usubillaga, R., Letembet, V., Brazille, P., Canouï, É., Slama, D., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002651 · Cited by 71

The Perfect Storm: COVID-19 Health Disparities in US Blacks

Phillips, N., Park, I.-W., Robinson, J. R., & Jones, H. P. (2020) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-020-00871-y · Cited by 77

COVID-19 mortality risk factors in older people in a long-term care center

Heras, E., Garibaldi, P., Boix, M., Valero, O., Castillo, J., Curbelo, Y., Gonzalez, E., Mendoza, O., Anglada, M., Miralles, J. C., et al. (2020) · European Geriatric Medicine · doi:10.1007/s41999-020-00432-w · Cited by 70

Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients

Chaudhary, R., Garg, J., Houghton, D. E., Murad, M. H., Kondur, A., Chaudhary, R., Wysokiński, W. E., & McBane, R. D. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2021.01.009 · Cited by 73

Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications: State of Art

Calabrese, M., Garofano, M., Palumbo, R., Pietro, P. D., Izzo, C., Damato, A., Venturini, E., Iesu, S., Virtuoso, N., Strianese, A., et al. (2021) · Life · doi:10.3390/life11030259 · Cited by 76

Kidney disease and COVID-19 disease severity—systematic review and meta-analysis

Singh, J., Malik, P., Patel, N., Pothuru, S., Israni, A., Chakinala, R. C., Hussain, M. R., Chidharla, A., Patel, H. A., Patel, S., et al. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00715-x · Cited by 71

Considerations for Obstetric Care during the COVID-19 Pandemic

Dotters-Katz, S. K., & Hughes, B. L. (2020) · American Journal of Perinatology · doi:10.1055/s-0040-1710051 · Cited by 73

The characteristics and outcomes of 681 severe cases with COVID-19 in China

Chen, F.-F., Zhong, M., Liu, Y., Zhang, Y., Zhang, K., Su, D.-Z., Meng, X., & Zhang, Y. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.07.003 · Cited by 70

A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19

González-Rubio, J., Navarro-López, C., López-Nájera, E., López-Nájera, A., Jiménez‐Díaz, L., Navarro‐López, J. D., & López, A. N. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17207394 · Cited by 72

Testing for COVID-19 in lung cancer patients

Passaro, A., Peters, S., Mok, T. S. K., Attili, I., Mitsudomi, T., & de Marinis, F. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.04.002 · Cited by 70

Clinical Features of COVID-19 and Factors Associated with Severe Clinical Course: A Systematic Review and Meta-AnalysisPreprint

Kumar, A., Arora, A., Sharma, P., Anikhindi, S. A., Bansal, N. K., Singla, V., Khare, S., & Srivastava, A. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3566166 · Cited by 69

Coronavirus Disease (COVID-19–SARS-CoV-2) and Nutrition: Is Infection in Italy Suggesting a Connection?

Cena, H., & Chieppa, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00944 · Cited by 72

Use of anakinra in severe COVID-19: A case report

Filocamo, G., Mangioni, D., Tagliabue, P. F., Aliberti, S., Costantino, G., Minoia, F., & Bandera, A. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.026 · Cited by 69

Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19

Solun, B., & Shoenfeld, Y. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100052 · Cited by 69

Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus

Omolo, C. A., Soni, N., Fasiku, V. O., Mackraj, I., & Govender, T. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173348 · Cited by 69

Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care

Gusev, E. I., Martynov, M. Y., Boyko, A. N., Voznyuk, I. A., Latsh, N. Y., Sivertseva, S. A., Спирин, Н. А., & Shamalov, N. A. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20201200617 · Cited by 74

Blockage of interleukin-1β with canakinumab in patients with Covid-19

Landi, L. M., Ravaglia, C., Russo, E., Cataleta, P., Fusari, M., Boschi, A., Giannarelli, D., Facondini, F., Valentini, I., Panzini, I., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78492-y · Cited by 70

The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection

Ho, K. S., Howell, D., Rogers, L. J., Narasimhan, B., Verma, H., & Steiger, D. J. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.02.021 · Cited by 69

Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study

Al‐Mufti, F., Amuluru, K., Sahni, R., Bekelis, K., Karimi, R., Ogulnick, J. V., Cooper, J., Overby, P. J., Nuoman, R., Tiwari, A., et al. (2021) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7134 · Cited by 69

Carbapenem-Resistant Klebsiella pneumoniae Infections in ICU COVID-19 Patients—A Scoping Review

Mędrzycka-Dąbrowska, W. A., Lange, S., Zorena, K., Dąbrowski, S., Ozga, D., & Tomaszek, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102067 · Cited by 69

Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh

Rahman, M. A., Shanjana, Y., Tushar, M. I., Mahmud, T., Rahman, G. M. S., Milan, Z. H., Sultana, T., Chowdhury, A. M. L. H., Bhuiyan, M. A., Islam, M. R., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255379 · Cited by 71

JAK inhibitors and COVID-19

Levy, G., Guglielmelli, P., Langmuir, P. B., & Constantinescu, S. N. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002838 · Cited by 70

Pathophysiological, immunological, and inflammatory features of long COVID

Böhmwald, K., Diethelm‐Varela, B., Rodríguez‐Guilarte, L., Rivera, T., Riedel, C. A., González, P. A., & Kalergis, A. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341600 · Cited by 80

Novel coronavirus SARS-CoV-2 and COVID-19. Practice recommendations for obstetric anaesthesia: what we have learned thus far

Bampoe, S., Odor, P. M., & Lucas, D. N. (2020) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2020.04.006 · Cited by 68

COVID-19 and lung cancer: risks, mechanisms and treatment interactions

Addeo, A., Obéid, M., & Friedlaender, A. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000892 · Cited by 71

Clinical characteristics and chest CT imaging features of critically ill COVID-19 patients

Zhang, N., Xu, X., Zhou, L.-Y., Chen, G., Li, Y., Yin, H., & Sun, Z. (2020) · European Radiology · doi:10.1007/s00330-020-06955-x · Cited by 69

COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?

Mondal, R., Lahiri, D., Deb, S., Bandyopadhyay, D., Shome, G., Sarkar, S., Paria, S. R., Thakurta, T. G., Singla, P., & Biswas, S. C. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02210-8 · Cited by 69

Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System

Roberts, J., Pritchard, A. L., Treweeke, A. T., Rossi, A. G., Brace, N., Cahill, P. A., MacRury, S. M., Wei, J., & Megson, I. L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.629933 · Cited by 68

The intersection of COVID-19 and cancer: signaling pathways and treatment implications

Zong, Z., Wei, Y., Ren, J., Zhang, L., & Zhou, F. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01363-1 · Cited by 74

Is Ferroptosis a Key Component of the Process Leading to Multiorgan Damage in COVID-19?

Pasini, A. M. F., Stranieri, C., Girelli, D., Busti, F., & Cominacini, L. (2021) · Antioxidants · doi:10.3390/antiox10111677 · Cited by 72

Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China

Li, L., Yang, L., Gui, S., Pan, F., Ye, T., Liang, B., Yu, H., & Zheng, C. (2020) · Theranostics · doi:10.7150/thno.46569 · Cited by 66

Cardiovascular implications of COVID-19 versus influenza infection: a review

Khan, M. S., Shahid, I., Anker, S. D., Solomon, S. D., Vardeny, O., Michos, E. D., Fonarow, G. C., & Butler, J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01816-2 · Cited by 68

Time to recovery from COVID-19 and its predictors among patients admitted to treatment center of Wollega University Referral Hospital (WURH), Western Ethiopia: Survival analysis of retrospective cohort study

Tolossa, T., Wakuma, B., Gebre, D. S., Merdassa, E., Getachew, M., Fetensa, G., Ayala, D., & Turi, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252389 · Cited by 68

Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (Covid-19) en pacientes con trasplante renal

López, V., Vázquez, T., Alonso-Titos, J., Cabello, M., Alonso, A., Beneyto, I., Crespo, M., Díaz‐Corte, C., Franco, A., González-Roncero, F. M., et al. (2020) · Nefrología · doi:10.1016/j.nefro.2020.03.002 · Cited by 66

COVID-19: La pandemia por el nuevo virus SARS-CoV-2

Accinelli, R. A., Xu, C. M. Z., Wang, J.-D. J., Yachachin-Chávez, J. M., Cáceres-Pizarro, J., Tafur, K. B., Tejada, R. G. F., & Paiva-Andrade, A. D. C. (2020) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2020.372.5411 · Cited by 66

Deciphering the TCR Repertoire to Solve the COVID-19 Mystery

Gutierrez, L., Beckford, J., & Alachkar, H. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.06.001 · Cited by 65

Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review

Das, S., Anu, K. R., Birangal, S., Nikam, A. N., Pandey, A. P., Mutalik, S., & Joseph, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118202 · Cited by 69

Correlating arterial blood gas, acid–base and blood pressure abnormalities with outcomes in COVID-19 intensive care patients

Bezuidenhout, M. C., Wiese, O. J., Moodley, D. L., Maasdorp, E., Davids, M. R., Koegelenberg, C. F. N., Lalla, U., Wamono, A. A. K., Zemlin, A. E., & Allwood, B. (2020) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563220972539 · Cited by 76

Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.

Blum, V. F., Cimerman, S., Hunter, J., Tierno, P. F. G. M. M., Lacerda, A. L. T., Soeiro, A. D. M., Cardoso, F., Bellei, N., Maricato, J. T., Mantovani, N., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100981 · Cited by 64

IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS

Lin, H., Scull, B., Goldberg, B. R., Abhyankar, H. A., Eckstein, O. S., Zinn, D. J., Lubega, J., Agrusa, J. E., Mallawaney, N. E., Gulati, N., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004287 · Cited by 69

Diabetes mellitus association with coronavirus disease 2019 (COVID‐19) severity and mortality: A pooled analysis

Aggarwal, G., Lippi, G., Lavie, C. J., Henry, B. M., & Sanchis‐Gomar, F. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13091 · Cited by 78

Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary

Keeley, P. W., Buchanan, D., Carolan, C. M., Pivodic, L., Tavabie, S., & Noble, S. (2020) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2020-002368 · Cited by 65

Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients

Gerussi, A., Rigamonti, C., Elia, C., Cazzagon, N., Floreani, A., Pozzi, R., Pozzoni, P., Claar, E., PASULO, L., FAGIUOLI, S., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1557 · Cited by 65

Could Ergothioneine Aid in the Treatment of Coronavirus Patients?

Cheah, I. K.-M., & Halliwell, B. B. (2020) · Antioxidants · doi:10.3390/antiox9070595 · Cited by 67

COVID‐19 in solid organ transplant recipients: No difference in survival compared to general population

Rinaldi, M., Bartoletti, M., Bussini, L., Pancaldi, L., Pascale, R., Comai, G., Morelli, M. C., Ravaioli, M., Cescon, M., Cristini, F., et al. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13421 · Cited by 62

Role of extracorporeal membrane oxygenation in COVID‐19: A systematic review

Haiduc, A. A., Alom, S., Melamed, N., & Harky, A. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14879 · Cited by 65

A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury

Kost‐Alimova, M., Sidhom, E.-H., Satyam, A., Chamberlain, B. T., Dvela‐Levitt, M., Melanson, M., Alper, S. L., Santos, J., Gutierrez, J., Subramanian, A., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100137 · Cited by 65

COVID-19 myocarditis and prospective heart failure burden

Shchendrygina, A., Nagel, E. C., Püntmann, V. O., & Valbuena-López, S. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2021.1844005 · Cited by 65

Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19: a systematic review and meta-analysis

Kiss, S., Gede, N., Hegyi, P. J., Németh, D. I., Földi, M., Dembrovszky, F., Nagy, B., Juhász, M. F., Ocskay, K., Zádori, N., et al. (2020) · Medical Microbiology and Immunology · doi:10.1007/s00430-020-00696-w · Cited by 67

Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm?

Vignesh, R., Swathirajan, C. R., Tun, Z. H., Rameshkumar, M. R., Solomon, S. S., & Balakrishnan, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607734 · Cited by 66

A Comparison of XGBoost, Random Forest, and Nomograph for the Prediction of Disease Severity in Patients With COVID-19 Pneumonia: Implications of Cytokine and Immune Cell Profile

Hong, W., Zhou, X., Jin, S., Lu, Y., Pan, J., Lin, Q., Yang, S., Xu, T., Basharat, Z., Zippi, M., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.819267 · Cited by 71

Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial

Farkhad, N. K., Sedaghat, A., Reihani, H., Moghadam, A. A., Moghaddam, A. B., Ghaebi, N. K., Khodadoust, M. A., Ganjali, R., Tafreshian, A. R., & Tavakol‐Afshari, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02920-1 · Cited by 64

Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?

Lu, L., Zhang, H., Zhan, M., Jiang, J., Yin, H., Dauphars, D. J., Li, S.-Y., Li, Y., & He, Y.-W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00677 · Cited by 67

Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool

Momtazmanesh, S., Shobeiri, P., Hanaei, S., Mahmoud-Elsayed, H. M., Dalvi, B. V., & Rad, E. M. (2020) · The Egyptian Heart Journal · doi:10.1186/s43044-020-00075-z · Cited by 64

Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study

Murk, W. K., Gierada, M., Fralick, M., Weckstein, A. R., Klesh, R., & Rassen, J. A. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.201686 · Cited by 64

Hyponatremia is associated with poor outcome in COVID-19

Carvalho, H. D., Letellier, T., Karakachoff, M., Desvaux, G., Caillon, H., Papuchon, E., Bentoumi-Loaec, M., Benaouicha, N., Canet, E., Chapelet, G., et al. (2021) · Journal of Nephrology · doi:10.1007/s40620-021-01036-8 · Cited by 62

Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications

Pasini, A. M. F., Stranieri, C., Cominacini, L., & Mozzini, C. (2021) · Antioxidants · doi:10.3390/antiox10020272 · Cited by 68

CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses

Jalloh, S., Olejnik, J., Berrigan, J. L., Nisa, A., Suder, E. L., Akiyama, H., Lei, M., Ramaswamy, S., Tyagi, S., Bushkin, Y., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010479 · Cited by 69

Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report

Bussalino, E., Maria, A. D., Russo, R., & Paoletti, E. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15920 · Cited by 63

Age-Adjusted Risk Factors Associated with Mortality and Mechanical Ventilation Utilization Amongst COVID-19 Hospitalizations—a Systematic Review and Meta-Analysis

Patel, U. K., Malik, P., Usman, M., Mehta, D., Sharma, A., Malik, F. A., Khan, N., Siddiqi, T. J., Ahmed, J., Patel, A., et al. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00476-w · Cited by 63

Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System

Sparks, M. A., South, A. M., Badley, A. D., Baker-Smith, C. M., BATLLE, D. C., Bozkurt, B., Cattaneo, R., Crowley, S. D., Dell’Italia, L. J., Ford, A. L., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15948 · Cited by 62

Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis

Cappabianca, S., Fusco, R., Lisio, A. D., Paura, C., Clemente, A., Gagliardi, G., Lombardi, G., Giacobbe, G., Maria, R. G., Paola, B. M., et al. (2020) · La radiologia medica · doi:10.1007/s11547-020-01293-w · Cited by 63

Systemic microvascular endothelial dysfunction and disease severity in COVID-19 patients: Evaluation by laser Doppler perfusion monitoring and cytokine/chemokine analysis

Sabioni, L. R., Lorenzo, A. D., Lamas, C. D. C., Muccillo, F., Castro-Faria-Neto, H. C., Estato, V., & Tibiriçá, E. V. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.104119 · Cited by 64

Cardiovascular biomarkers in patients with COVID-19

Mueller, C. E., Giannitsis, E., Jaffe, A. S., Huber, K., Mair, J. M., Cullen, L., Hammarsten, O., Mills, N. L., Möckel, M. M., Krychtiuk, K. A., et al. (2021) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuab009 · Cited by 63

The central role of mitochondrial fitness on antiviral defenses: An advocacy for physical activity during the COVID-19 pandemic

Burtscher, J., Burtscher, M., & Millet, G. P. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101976 · Cited by 67

Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review

Aleksova, A., Gagno, G., Sinagra, G., Beltrami, A. P., Janjusevic, M., Ippolito, G., Zumla, A. I., Fluca, A. L., & Ferro, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094526 · Cited by 64

Relative Lymphocytosis in COVID-19—A Ray of Hope

Ish, P., Malhotra, N., Agrawal, S. P., & Gupta, N. (2020) · Advances in respiratory medicine · doi:10.5603/arm.a2020.0098 · Cited by 11

15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study

Wang, K., Zhang, Z., Yu, M., Tao, Y., & Xie, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06047-w · Cited by 87

Short Term Outcomes and Risk Factors for Mortality in Patients with COVID-19 in Wuhan, China: A Retrospective StudyPreprint

Zhang, S., Guo, M., Duan, L., Wu, F., Wang, Z., Xu, J., Ma, Y., Lv, Z., Tan, X., Zhang, S., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3551390 · Cited by 8

“Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.” Rong-Hui Du, Li-Rong Liang, Cheng-Qing Yang, Wen Wang, Tan-Ze Cao, Ming Li, Guang-Yun Guo, Juan Du, Chun-Lan Zheng, Qi Zhu, Ming Hu, Xu-Yan Li, Peng Peng and Huan-Zhong Shi. Eur Respir J 2020; 55: 2000524.

European Respiratory Society (2020) · European Respiratory Journal · doi:10.1183/13993003.50524-2020 · Cited by 18

Clinical prediction model for mortality of adult diabetes inpatients with COVID-19 in Wuhan, China: A retrospective pilot study

Su, M., Yuan, J., Peng, J., Wu, M., Yang, Y., & Peng, Y. (2020) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2020.109927 · Cited by 5